INTERNATIONAL JOURNAL OF ONCOLOGY
| [0012]
|
Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer
| [0135]
|
Physical status of HPV types 16 and 18 in topographically different areas of genital tumours and in paired tumour-free mucosa
| [0135]
|
HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness
| [0135]
|
The causal relation between human papillomavirus and cervical cancer
| [0135]
|
A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer
| [0135]
|
Analysis of deletion of the integrated human papillomavirus 16 sequence in cervical cancer: a rapid multiplex polymerase chain reaction approach
| [0135]
|
Viral load, E2 gene disruption status, and lineage of human papillomavirus type 16 infection in cervical neoplasia
| [0135]
|
HPV type-distribution in women with and without cervical neoplastic diseases
| [0135]
|
Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions
| [0135]
|
Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study
| [0135]
|
A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8
| [0135]
|
Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix
| [0135]
|
Natural history of cervicovaginal papillomavirus infection in young women
| [0135]
|
Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities
| [0135]
|
Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer
| [0135]
|
Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas
| [0135]
|
Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis
| [0135]
|
Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes
| [0135]
|
Human papillomavirus-positive tonsillar carcinomas: a different tumor entity?
| [0135]
|
Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines
| [0135]
|
Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells
| [0135]
|
Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping
| [0135]
|
Genomic changes and HPV type in cervical carcinoma
| [0135]
|
Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines
| [0135]
|
The burden of HPV-related cancers
| [0135]
|
Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique
| [0135]
|
RespiFinder: a new multiparameter test to differentially identify fifteen respiratory viruses
| [0135]
|
The performance of the HPV16 real-time PCR integration assay
| [0135]
|
Human papillomavirus infection: biology, epidemiology, and prevention
| [0135]
|
Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification
| [0135]
|
Human papillomavirus type 16 DNA sequence
| [0135]
|
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas
| [0135]
|
Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions
| [0135]
|
Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer
| [0135]
|
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
| [0135]
|
Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix
| [0135]
|
A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques
| [0135]
|
Papillomaviruses and cancer: from basic studies to clinical application
| [0135]
|
Picogram per cell determination of DNA by flow cytofluorometry
| [0135]
|
Type-specific persistence of high-risk human papillomavirus infections in the New Independent States of the former Soviet Union Cohort Study
| [0135]
|
Comparison of the PapilloCheck DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set
| [0135]
|